18.104.22.168 Somatostatin Analogues
Treatment should only be initiated on the advice of a hospital specialist.
Lanreotide (injection) and octreotide (injection) are analogues of the hypothalamic release-inhibiting hormone somatostatin. They are indicated for the relief of symptoms associated with neuroendocrine (particularily carcinoid) tumours and acromegaly. Lanreotide is also licensed for the treatment of thyroid tumours and octreotide is licensed for the prevention of complications following pancreatic surgery.